A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 326



Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart, Michael Friedlander, Stephen Fox, David Bowtell, Gillian Mitchell. J Clin Oncol 2012
Times Cited: 654




List of shared articles



Times cited

Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
Eloise Chapman-Davis, Zhen Ni Zhou, Jessica C Fields, Melissa K Frey, Bailey Jordan, Katherine J Sapra, Sudeshna Chatterjee-Paer, Ann D Carlson, Kevin M Holcomb. J Gen Intern Med 2021
0

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Felipe Leonardo Estati, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Adriana Regina Gonçalves Ribeiro, Maria Nirvana Formiga, Giovana Tardin Torrezan, Dirce Maria Carraro, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa. Ann Surg Oncol 2021
3

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
10

FLABRA, frontline approach for BRCA testing in an ovarian cancer population: a Latin America epidemiologic study.
Gonzalo Giornelli, Dolores Gallardo, Roberto Hegg, Gonzalo Gomez Abuin, Maximo De La Vega, Maria Lim-Law, Valeria Caceres, Lina Trujillo, Maria Del Pilar Estevez-Diz, Cristian Pacheco,[...]. Future Oncol 2021
0

Controversies in Hereditary Cancer Management.
Mariam M AlHilli, Holly J Pederson. Obstet Gynecol 2021
0

Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients.
Gang Ji, Qianlan Yao, Longlong Bao, Jing Zhang, Qianming Bai, Xiaoli Zhu, Xiaoyu Tu, Rui Bi, Xiaoyan Zhou. Ann Transl Med 2021
0

Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.
Hee-Sung Ahn, Jung Yoon Ho, Jiyoung Yu, Jeonghun Yeom, Sanha Lee, Soo Young Hur, Yuyeon Jung, Kyunggon Kim, Youn Jin Choi. Cancers (Basel) 2021
0


Epithelial ovarian cancer risk: A review of the current genetic landscape.
Nicola Flaum, Emma J Crosbie, Richard J Edmondson, Miriam J Smith, Dafydd G Evans. Clin Genet 2020
7

Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants.
Nicola Flaum, Emma J Crosbie, Emma R Woodward, Fiona Lalloo, D Gareth Evans. Eur J Cancer 2020
1

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
36

Genetic testing for epithelial ovarian cancer.
Noa Amin, Narda Chaabouni, Angela George. Best Pract Res Clin Obstet Gynaecol 2020
1

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer.
Yan You, Lei Li, Junliang Lu, Huanwen Wu, Jing Wang, Jie Gao, Ming Wu, Zhiyong Liang. Front Oncol 2020
4

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes.
Deepak N Subramanian, Magnus Zethoven, Simone McInerny, James A Morgan, Simone M Rowley, Jue Er Amanda Lee, Na Li, Kylie L Gorringe, Paul A James, Ian G Campbell. Nat Commun 2020
4

Population Screening for Inherited Predisposition to Breast and Ovarian Cancer.
Ranjit Manchanda, Sari Lieberman, Faiza Gaba, Amnon Lahad, Ephrat Levy-Lahad. Annu Rev Genomics Hum Genet 2020
8

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Solene De Talhouet, Julien Peron, Aurelie Vuilleumier, Alex Friedlaender, Valeria Viassolo, Aurélie Ayme, Alexandre Bodmer, Isabelle Treilleux, Noemie Lang, Jean- Christophe Tille,[...]. Sci Rep 2020
8


Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.
Stephanie Alimena, Lauren Scarpetti, Erica L Blouch, Linda Rodgers, Kristen Shannon, Marcela Del Carmen, Annekathryn Goodman, Whitfield B Growdon, Eric Eisenhauer, Rachel Clark Sisodia. Int J Gynecol Cancer 2020
1

How can Australia integrate routine genetic sequencing in oncology: a qualitative study through an implementation science lens.
Rosie O'Shea, Nicole M Rankin, Maira Kentwell, Margaret Gleeson, Lucinda Salmon, Katherine M Tucker, Sarah Lewis, Natalie Taylor. Genet Med 2020
1

Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
Susan Randall Armel, Alexandra Volenik, Rochelle Demsky, Janet Malcolmson, Manjula Maganti, Jeanna McCuaig. Gynecol Oncol 2020
2

Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1

DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome.
Kristyna Tomasova, Andrea Cumova, Karolina Seborova, Josef Horak, Kamila Koucka, Ludmila Vodickova, Radka Vaclavikova, Pavel Vodicka. Cancers (Basel) 2020
5


Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Arielle S Weiss, Elizabeth Swisher, Kathryn P Pennington, Marc Radke, Nithisha Khasnavis, Rochelle L Garcia, Mark R Kilgore, Ming K Lee, Barbara M Norquist. Gynecol Oncol 2020
0